Savara
SVRA
#5360
Rank
A$2.09 B
Marketcap
A$10.29
Share price
2.47%
Change (1 day)
95.29%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2025 (TTM): -A$0.19 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$0.15 Billion a decrease over its 2023 earnings that were of -A$82.12 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.19 Billion25.26%
2024 -A$0.15 Billion75.29%
2023 -A$82.12 Million43.38%
2022 -A$57.28 Million-11.31%
2021 -A$64.58 Million-13.3%
2020 -A$74.49 Million-36.53%
2019 -A$0.12 Billion13.76%
2018 -A$0.11 Billion105.54%
2017 -A$50.2 Million34.11%
2016 -A$37.43 Million-37.43%
2015 -A$59.82 Million38.81%
2014 -A$43.1 Million33.62%
2013 -A$32.25 Million38.49%
2012 -A$23.29 Million24.59%
2011 -A$18.7 Million-36.5%
2010 -A$29.44 Million-3.14%
2009 -A$30.39 Million-23.28%
2008 -A$39.61 Million8.52%
2007 -A$36.5 Million-34.14%
2006 -A$55.43 Million184.43%
2005 -A$19.49 Million90.75%
2004 -A$10.22 Million190.35%
2003 -A$3.52 Million11.64%
2002 -A$3.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-A$27.26 Million-84.30%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-A$0.24 Billion 37.90%๐Ÿ‡บ๐Ÿ‡ธ USA